Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Plaque Psoriasis × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 4 Psoriasis 2 Crohn Disease 2 Uveal Melanoma 1 Spondylitis, Ankylosing 1 Plaque Psoriasis 1 Melanoma 1 Healthy Adult Male 1 Healthy 1 Colitis, Ulcerative 1

Interventions

Adalimumab 1 ABP 501 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05073315 2024-02-09

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Amgen

Phase 3 Completed

425 enrolled 22 charts

Plaque Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡